TD Cowen analyst Robert Moskow lowered the firm’s price target on Vital Farms (VITL) to $44 from $59 and keeps a Buy rating on the shares. The firm attended its investor day where the company established an aggressive $2B sales target for 2030, driven by shelf space expansion, growing brand awareness and household penetration, and unlocking capacity constraints. However, its 2025 guidance cut reinforced market concerns about susceptibility to an increasingly crowded premium egg category and price sensitive consumer.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VITL:
- Vital Farms price target lowered to $47 from $52 at DA Davidson
- Vital Farms price target lowered to $50 from $60 at BMO Capital
- Vital Farms price target lowered to $45 from $48 at Morgan Stanley
- Midday Fly By: Ford takes $19.5B EV writedown, Apple expanding iPhone lineup
- Vital Farms: Long-Term Growth Potential Outweighs Minor Short-Term Revenue Adjustment